Cargando…
Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm
Most treatment guidelines, including those from the American Diabetes Association/European Association for the Study of Diabetes and the International Diabetes Federation, suggest metformin be used as the first-line therapy after diet and exercise. This recommendation is based on the considerable bo...
Autores principales: | Abdul-Ghani, Muhammad, DeFronzo, Ralph A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521981/ https://www.ncbi.nlm.nih.gov/pubmed/28733377 http://dx.doi.org/10.2337/dc16-2368 |
Ejemplares similares
-
Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: The time has come for GLP-1 receptor agonists!
por: Schwartz, Stanley, et al.
Publicado: (2013) -
POINT: Tracheostomy in Patients With COVID-19: Should We Do It Before 14 Days? Yes
por: Brenner, Michael J., et al.
Publicado: (2021) -
POINT: Should Fellowship Interviews Remain Exclusively
Virtual? Yes
por: Çoruh, Başak
Publicado: (2021) -
Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: It is time to face the evidence
por: Malanda, Uriëll L., et al.
Publicado: (2013) -
Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: Insulin therapy has proven itself and is considered the mainstay of treatment
por: Umpierrez, Guillermo E., et al.
Publicado: (2013)